Recombinant Anti-CD55 x Anti-HLA-A Bispecific Antibody (Minibody) is designed to be expressed as the anti-CD55 scFv fused to N-terminus of Knob-CH3 domain and the anti-HLA-A scFv to the Hole-CH3 domain, or vice versa. The CH3 domains are further stabilized by C-terminal disulfide bonds. This BsAb can recruit complements to tumor cells. It is designed for the research of Renal cell cancer (RCC); Solid tumors therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY